# A Study of Lanadelumab in Teenagers and Adults With Hereditary Angioedema (HAE)

> **NCT05469789** · — · ACTIVE_NOT_RECRUITING · sponsor: **Takeda** · enrollment: 50 (estimated)

## Conditions studied

- Hereditary Angioedema (HAE)

## Interventions

- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT05469789
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-06-29
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05469789

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05469789, "A Study of Lanadelumab in Teenagers and Adults With Hereditary Angioedema (HAE)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05469789. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*